drugset / Trial / NCT00767975

Active Screening of Latent TB Infection, Treatment and Long Term Follow-up in Prison

NCT00767975

Phase 3 Completed 2384 enrolled National Taiwan University Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

LTBI Treatment is effective in prison

Timeline

Start
2008-01
Primary completion
2010-11
Completion
2010-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Isoniazid Small molecule 300 mg
Subject Rifampin Small molecule 600 mg

Indications